Kymera Therapeutics (KYMR) Revenue & Revenue Breakdown
Kymera Therapeutics Revenue Highlights
Latest Revenue (Y)
$39.20M
Latest Revenue (Q)
$2.76M
Kymera Therapeutics Revenue by Period
Kymera Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $39.20M | -16.72% |
| 2024-12-31 | $47.07M | -40.11% |
| 2023-12-31 | $78.59M | 67.84% |
| 2022-12-31 | $46.83M | -35.71% |
| 2021-12-31 | $72.83M | 114.00% |
| 2020-12-31 | $34.03M | 1059.99% |
| 2019-12-31 | $2.93M | 100.00% |
| 2018-12-31 | - | - |
Kymera Therapeutics generated $39.20M in revenue during NA 2025, up -16.72% compared to the previous quarter, and up 115.18% compared to the same period a year ago.
Kymera Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $2.76M | -75.91% |
| 2025-06-30 | $11.48M | -48.07% |
| 2025-03-31 | $22.10M | 198.89% |
| 2024-12-31 | $7.39M | 97.65% |
| 2024-09-30 | $3.74M | -85.42% |
| 2024-06-30 | $25.65M | 149.34% |
| 2024-03-31 | $10.29M | -78.52% |
| 2023-12-31 | $47.88M | 912.80% |
| 2023-09-30 | $4.73M | -71.37% |
| 2023-06-30 | $16.51M | 74.45% |
| 2023-03-31 | $9.47M | -41.35% |
| 2022-12-31 | $16.14M | 68.98% |
| 2022-09-30 | $9.55M | -17.05% |
| 2022-06-30 | $11.51M | 19.66% |
| 2022-03-31 | $9.62M | -37.01% |
| 2021-12-31 | $15.28M | -24.89% |
| 2021-09-30 | $20.34M | 9.81% |
| 2021-06-30 | $18.52M | -0.98% |
| 2021-03-31 | $18.70M | 46.28% |
| 2020-12-31 | $12.79M | -12.03% |
| 2020-09-30 | $14.53M | 342.00% |
| 2020-06-30 | $3.29M | -4.08% |
| 2020-03-31 | $3.43M | 87.02% |
| 2019-12-31 | $1.83M | 92.95% |
| 2019-09-30 | $950.00K | - |
Kymera Therapeutics generated $2.76M in revenue during Q3 2025, up -75.91% compared to the previous quarter, and up 10.78% compared to the same period a year ago.
Kymera Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AAPG | ASCENTAGE PHARMA GROUP | $980.65M | $141.22K |
| ACAD | ACADIA Pharmaceuticals | $957.80M | $278.63M |
| SLNO | Soleno Therapeutics | $190.41M | $66.02M |
| KYMR | Kymera Therapeutics | $39.20M | $2.76M |
| NAMS | NewAmsterdam Pharma | $22.50M | $19.14M |
| CRNX | Crinetics Pharmaceuticals | $5.42M | $143.00K |
| AKRO | Akero Therapeutics | - | - |
| VKTX | Viking Therapeutics | - | - |
| IMVT | Immunovant | - | - |
| ACLX | Arcellx | - | $7.55M |
| PRAX | Praxis Precision Medicines | - | - |